MXenes,
a family of two-dimensional (2D) transition-metal carbide
and nitride materials, are supposed to be promising pseudocapacitive
materials because of their high electronic conductivity and hydrophilic
surfaces. MXenes, prepared by removing the “A” elements
of their corresponding MAX phases by hydrofluoric acid (HF) or LiF–HCl
etching, possess abundant terminal groups like −F, −OH,
and −O groups. It has been proven that the MXenes with fewer
−F terminal groups and more −O groups showed a higher
pseudocapacitor performance. In organic reactions, −OH and
−X (X = halogen) groups could turn to ether groups in strong
nucleophilic reagent. Inspired by that, herein, we report an n-butyllithium-treated method to turn the −F and
−OH terminal groups to −O groups on the Ti3C2T
x
MXenes. Two types of
Ti3C2T
x
MXenes prepared
by either HF or LiF–HCl etching were systematically investigated,
and a comparison with the traditional KOH/NaOH/LiOH-treated method
was also carried out. It is found that most of the −F terminal
groups on the Ti3C2T
x
MXenes can be successfully removed by n-butyllithium,
and abundant −O terminal groups were formed. The n-butyllithium-treated Ti3C2T
x
MXenes show promising applications in high-performance pseudocapacitors.
A record high capacitance of 523 F g–1 at 2 mV s–1 was obtained for the n-butyllithium-treated
Ti3C2T
x
MXenes,
and 96% capacity can remain even after 10 000 cycles.
We developed a new strategy to controllably oxidize Ti3C2Tx by readily adjusting the loading of ammonium persulfate, in order to turn the –F terminal groups to –O terminal groups on the Ti3C2Tx MXene, contributing to high performance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.